FDA — authorised 26 June 2024
- Application: NDA217389
- Marketing authorisation holder: MSD
- Local brand name: OHTUVAYRE
- Indication: SUSPENSION — INHALATION
- Status: approved
🇺🇸 Ohtuvayre in United States
FDA authorised Ohtuvayre on 26 June 2024
Marketing authorisations
FDA
- Marketing authorisation holder: VERONA PHARMA
- Status: approved
Ohtuvayre in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in United States
Frequently asked questions
Is Ohtuvayre approved in United States?
Yes. FDA authorised it on 26 June 2024; FDA has authorised it.
Who is the marketing authorisation holder for Ohtuvayre in United States?
MSD holds the US marketing authorisation.